Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 273 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q2
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q2
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q2
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View →
Q2
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $30,000.00 income
Health Issues
View →
Q2
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income
Health Issues
View →
Q2
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
RR
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts
Pharmacy
View →
Q2
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues
View →
1A
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View →
Q1
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate
Health Issues
View →
Q1
YC CONSULTING, LLC for PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues
View →
Q1
ALSTON & BIRD LLP for ST. JUDE CHILDREN'S RESEARCH HOSPITAL
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate
Health Issues
View →
Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
SPARK THERAPEUTICS, INC. for SPARK THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate
Medicare/Medicaid, Health Issues
View →
Q1
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q1
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code
View →
Q1
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q1
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Budget/Appropriations
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
INCYTE CORPORATION for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q1
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $420,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Animals, Budget/Appropriations, Chemicals/Chemical Industry
View →
1A
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Science/Technology
View →
Previous Page 10 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem